Nyheter
Negotiations for 2025 have ended. FinELib consortium will not sign an agreement with American Chemical Society.
→ Läs meraThere will be no consortium agreement for 2024, but negotiations will continue for the year 2025.
→ Läs meraNew agreements will ensure continuation of open access publishing, guarantee access to journals, and keep the expenses of scientific publishing moderate.
→ Läs meraAccess to new, 2024 published ACS articles has been cut, and open access publishing under FinELib agreements has ended.
→ Läs meraFinELib has made progress in negotiating with scholarly publishers, and negotiations continue in the new year.
→ Läs meraAre you planning on publishing your article open access under a FinELib agreement? Check what you need to know.
→ Läs meraLooking for better value 14.11.2023 Which scholarly journal agreements offer good value for money for higher education and research? Which agreements make a difference for open publishing, and which agreements give access to the most important journals? And above all, what is a fair and sustainable price for this? FinELib consortium is seeking answers to … Jatka artikkeliin Looking for better value
→ Läs meraIt’s no longer possible to publish open access at Nature journals with FinELib’s agreement.
→ Läs meraUtnyttja Open access -fördelar
Vid förhandlingarna har man kommit överens om open access-fördelar för följande förläggares tidskrifter.
Mer information om open access-fördelar för olika förläggare och organisationer får du även på ditt eget bibliotek.